Documents & Forms
For your convenience, we've put these commonly used documents together in one place. You'll also find news and updates for all lines of business. Start by choosing your patient's network listed below.
- Commercial
- Medicare Advantage
- Medicare with Medicaid (BlueCare PlusSM)
- Medicaid (BlueCare)
- TennCareSelect
- CoverKids
- BlueCare CHOICES
- SelectCommunity
- BlueCard
- Dental
- Behavioral Health
- Current Lab Testing Policies
- Enrollment
- Technical Support
- News & Updates
Commercial
These manuals are your source for important information about our policies and procedures.
Forms and information to help you request prior authorization or file an appeal.
- Provider Reconsideration Form
-
Provider Appeal Form
(Claim Reconsideration Appeal)
- Utilization Management Appeal Form
- Air Ambulance Fax Form
- Bariatric Surgery Authorization Request Form
- Care Management Contact Information
- Cite Guideline Quick Reference Guide
- Commercial Hospice Service Request Form
- Commercial Long Term Acute Care Hospitalization Request Form
- Commercial Lab Sleep Study Form
- Commercial Lab Sleep Studies Program CPT List
- Commercial/FEP Transplant Request Form
- Durable Medical Equipment (DME) Authorization Request
- Complex Rehab Tech (CRT) DME Authorization Request
- Federal Employee Program and Postal Prior Approval List
- Federal Employee and Postal Gender Affirming Surgery Prior Approval Request Form
- Federal Employee and Postal Predetermination / Prior Approval Form
- Federal Employee and Postal Hearing Aid Prior Approval Request Form
- Federal and Postal Employee Program Provider-Administered Medication Authorization Form
- Gender Reassignment Surgery Pre-certification Request Form
- Genetic Testing Authorization Request (Effective 9/1/24)
- High Tech Imaging Authorization Codes
- High Tech Imaging Authorization Request Form
- Home Health Services Request
- Inpatient/Outpatient Services Prior Authorization Request Form
- Medical Policy Appeals Process
- Musculoskeletal Epidural Steroid Injection Request (Vendor: Turning Point)
- Musculoskeletal Facet Joint Injection Request (Vendor: Turning Point)
- Musculoskeletal Joint and Spine Authorization Request (Vendor: Turning Point)
- Musculoskeletal Neurotomy Request (Vendor: Turning Point)
- Musculoskeletal Procedure/Pain Management Codes
- Predetermination Request
- Prior Authorization List
- Prior Authorization Start & Term Dates
- Provider-Administered Medication Authorization
- Provider Attestation for Abortion Services
- Provider Attestation Form for Gender-Affirming Services
- Radiation Oncology Authorization Request (Effective 9/1/24)
- Radiation Oncology Therapy CPT Codes
- Skilled Nursing Facility/Inpatient Rehabilitation Authorization Request
Appeals
Authorizations
Forms and information about behavioral health services for your patients
- Applied Behavioral Analysis (ABA) Therapy Services Request Form
- Applied Behavioral Analysis (ABA) Initiation and Continuation Request Form
- Buprenorphine Medication Assisted Treatment (BMAT) Program Description
- Clinical Discharge Form
- Commercial Psychiatric Clinical Service Authorization Request Form
- Psychological Testing Authorization Request Form
- Substance Abuse Clinical Service Authorization Request Form
- Transcranial Magnetic Stimulation (TMS) Pre-Authorization Request Form
Forms and information about pharmacy services and prescriptions for your patients.
- 2025 Essential Medication List (Formulary)
- 2026 Essential Medication List (Formulary)
- 2026 What's Changing Document: Essential Medication List (Formulary)
- 2025 Essential Plus Medication List (Formulary)
- 2026 Essential Plus Medication List (Formulary)
- 2026 What's Changing Document: Essential Plus Medication List (Formulary)
- 2025 Preferred Medication List (Formulary)
- 2025 BlueCross Preventive Medication List
- 2025 Choice Medication List (Formulary)
- 2026 Choice Medication List (Formulary)
- 2025 Control Medication List (Formulary)
- 2026 Control Medication List (Formulary)
- 2025 Control and Choice Preventive Drug List
- Affordable Care Act (ACA) $0 Copay Preventive List
- Controlled Substance Prescribing
- Stimulant Prescribing Guidelines
- Immunizing Pharmacist Vaccine Code List
- Medical Exclusions Medication List
- Medication Review Request Fax Cover
- Opioid Criteria
- OTC Savings Program
- Prescription Exception Request Form
- Prescription Mail Service Order Form
- Preferred, Essential, and Essential Plus Prior Authorization Criteria
- Control and Choice Prior Authorization Criteria
- Upcoming Prior Authorization Changes
- Provider Administered Specialty Medication List (Updated: 12/2/2025)
- Provider-Administered Medication Authorization
- Provider Administered Specialty Medication Step Therapy Guide
- Provider Advanced Specialty Benefit Management Exception Request Form
- Specialty Pharmacy Network List
Information to help you maximize your performance in our quality programs.
- Episodes of Care Quick Reference Guide
- Episode of Care Risk Adjustment Methodology
- Guide to Reading Your Episode of Care Report
- Low Back Pain Coding Tool
- Low Back Pain Provider Toolkit
- Quality Care Measures & Comprehensive Program Information Guide
- THCII State Employee Health Plan and Fully Insured Program Guide
- THCII State Employee Health Plan and Fully Insured - FAQs
Medicare Advantage
Forms and information to help you request prior authorization or file an appeal.
- Provider Reconsideration Form
- Provider Appeal Form
(Claim Reconsideration Appeal)
-
Utilization Management Appeal Form
- 2026 Special Supplemental Benefit for the Chronically Ill Attestation Form
- Administered Part-B Specialty Drug List
- BlueAdvantage Total Heart & Diabetes Provider Attestation Form
- Care Management Contact Information
- Cite Guideline Quick Reference Guide
- Claim Status Check Form
- CMS Inpatient Only List
- Detailed Notice of Discharge
- Durable Medical Equipment (DME) Authorization Request Form
- Home Health Outpatient Therapies Service Request Form
- Inpatient/Outpatient Service Request Form
- Master Prior Authorization List
- Medicare Home Health Face-to-Face Encounter
- Medical Policy Appeals Process
- MSK Injection Authorization Request Form
- Notice of Medicare Non Coverage
- PPO FAQs
- PPO fax cover sheet
- Predetermination Authorization Request Form
- Provider Reference Guide / Prior Authorization List
- Skilled Nursing Facility/Inpatient Rehabilitation Authorization Request
Appeals
Authorizations
Forms and information about pharmacy services and prescriptions for your patients.
- 2026 BlueAdvantage and Total Heart & Diabetes Medication List (Formulary)
- 2025 Medicare Advantage (BlueAdvantage) Medication List (Formulary)
- 2026 BlueAdvantage Extra and Total Heart & Diabetes Plus Medication List (Formulary)
- 2025 Medicare Advantage (BlueAdvantage Extra) Medication List (Formulary)
- 2025 Medicare Part D Prior Authorization Criteria (Updated: 9/1/2025)
- 2026 Medicare Part D Prior Authorization Criteria (Updated: 10/21/2025)
- Medicare Part B Prior Authorization Criteria
- Controlled Substance Prescribing
- Immunizing Pharmacist Vaccine Code List
- Part B Step Therapy Reference Guide (Updated: 12/2/2025)
- Part D - Prescription Hierarchical Condition Categories (RxHCC)
- Prescription Mail Service Order Form
- Provider Administered Specialty Medication List (Updated: 12/2/2025)
- Provider-Administered Medication Authorization Form
- Prescription Mail Service Order Form
Information to help you maximize your performance in our quality programs.
- 4 STAR and Above Providers
- Cognitive Assessment Tool
- Diabetes Prevention Program
- Depression Screening Tool
- Differences Between Statin Star Measures
- Fall Risk Assessment Tool
- Guide to Advanced Illness and Frailty Exclusions
- PCP Change Form
- Physician Now FAQs
- Quality+ Partnerships Program Guide
- Quality+ Partnership Program Measures
- Risk Adjustment Program
Medicare with Medicaid (BlueCare PlusSM)
Forms and information to help you request prior authorization or file an appeal.
- Provider Reconsideration Form
-
Provider Appeal Form (Claim Reconsideration Appeal)
- Advance Determination Decision
- Advance Determination Request
- Care Management Contact Information
- Certificate of Medical Necessity for Abortion Form
- Cite Guideline Quick Reference Guide
- Cite Guideline Transparency
- Consent for Sterilization Form
- Durable Medical Equipment (DME) Intake Fax Form
- High Tech Imaging C Code Crosswalk Reference Guide
- High Tech Imaging Codes Requiring Authorization
- Home Health Missed Visit Form
- Inpatient/Outpatient Services Request Form
- Instructions for completing Certificate of Medical Necessity for Abortion
- Instructions for completing Consent for Sterilization Form
- Medical Policy Appeals Process
- Medicare Advantage Provider- Administered Part-B Specialty Drug List
- MSK Procedure/Pain Management Codes
- Private Duty Nursing/Home Health Plan of Care
- Private Duty Nursing Home Plan of Care Agreement
- Recertification Member/Caregiver Training Checklist
- Skilled Nursing Facility Rehab Form
- Skilled Nursing Facility/Inpatient Rehabilitation Authorization Request
- Waiver of Liability Statement
Appeals
Authorizations
Forms and information about pharmacy services and prescriptions for your patients.
- 2026 BlueCare Plus & BlueCare Plus Choice Medication List (Formulary)
- 2025 Medicare with Medicaid (BlueCare Plus) Medication List (Formulary)
- 2026 BlueCare Plus Select Medication List (Formulary)
- 2025 Medicare Part D Prior Authorization Criteria (Updated: 9/1/2025)
- Medicare Part B Prior Authorization Criteria
- Provider-Administered Specialty Medication List (Updated: 12/2/2025)
- Provider-Administered Medication Authorization Form
- Controlled Substance Prescribing
- Part B Step Therapy Reference Guide (Updated: 12/2/2025)
Information to help you maximize your performance in our quality programs.
Medicaid (BlueCare)
TennCareSelect
CoverKids
BlueCare CHOICES
SelectCommunity
BlueCard
Information about benefits for your patients covered by the BlueCard program.
Dental
These documents contain information about your benefits, network and coverage.
- 2020 Dental Overview for Guidewell
- Acknowledgement of Financial Responsibility for the Cost of Dental Services
- Dental Claim Form
- Dental Claim Form Instructions
- Dental Office Implementation Guide
- Individual Dental Coverage Policy Prior 2017 and After
- Individual Dental Coverage Policy Prior to 2017
- National Dental GRID Network
Behavioral Health
These documents contain information about your benefits, network and coverage.
- Applied Behavioral Analysis (ABA) Therapy Services Request Form
- Applied Behavioral Analysis (ABA) Initiation and Continuation Request Form
- American Academy of Pediatrics Trauma Toolbox for Primary Care
- Psychological Testing Authorization Form (Commercial)
- Behavioral Health Adverse Occurrence Report Form
- Behavioral Health Levels of Care Program Descriptions
- Commercial Psychiatric Clinical Service Authorization Request Form
- Commercial Substance Abuse Clinical Service Authorization Request Form
- Transcranial Magnetic Stimulation (TMS) Pre-Authorization Request Form
- Clinical Discharge Form
Current Lab Testing Policies
- B - Hemolytic Streptococcus Testing – G2159
- Biochemical Markers of Alzheimer Disease and Dementia - G2048
- Biomarkers for Myocardial Infarction and Chronic Heart Failure – G2150
- Bone Turnover Markers Testing – G2051
- Cardiovascular Disease Risk Assessment (Commercial, MA, D-SNP) - G2050
- Cardiovascular Disease Risk Assessment (FEP) – G2050
- Celiac Disease Testing – G2043
- Cervical Cancer Screening (Commercial) – G2002
- Cervical Cancer Screening (FEP, MA, D-SNP) – G2002
- Diagnostic Testing of Common Sexually Transmitted Infections – G2157
- Diagnostic Testing of Influenza – G2119
- Epithelial Cell Cytology in Breast Cancer Risk Assessment – G2059
- Fecal Analysis in the Diagnosis of Intestinal and Fecal Microbiota Transplant Testing (Commercial, MA, D-SNP) – G2060
- Fecal Analysis in the Diagnosis of Intestinal and Fecal Microbiota Transplant Testing (FEP) – G2060
- Fecal Calprotectin Testing in Adults (Commercial, MA, D-SNP; not adopted for FEP) – G2061
- Flow Cytometry – F2019
- Folate Testing – G2154
- Gamma-glutamyl Transferase Testing in Adults – G2173
- General Inflammation Testing – G2155
- Hepatitis Testing (Commercial, MA, D-SNP) – G2036
- Hepatitis Testing (FEP) – G2036
- Identification of Microorganisms Using Nucleic Acid Probes – M2097
- Immunopharmacologic Monitoring of Therapeutic Serum Antibodies (Commercial, MA, D-SNP) – G2105
- Immunopharmacologic Monitoring of Therapeutic Serum Antibodies (FEP) – G2105
- In Vitro Chemoresistance and Chemosensitivity Assays (Commercial, MA, D-SNP) – G2100
- In Vitro Chemoresistance and Chemosensitivity Assays (FEP) – G2100
- Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease (Commercial, MA, D-SNP) – G2121
- Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease (FEP) G2121
- Metabolites Markers of Thiopurines Testing – G2115
- Nerve Fiber Density Testing – M2112
- Oral Cancer Screening and Testing (Commercial, MA, D-SNP) – G2113
- Oral Cancer Screening and Testing (FEP) – G2113
- Pancreatic Enzyme Testing for Acute Pancreatitis – G2153
- Pathogen Panel Testing (Commercial, MA, D-SNP) – G2149
- Pathogen Panel Testing (FEP) – G2149
- Prenatal Testing (Nongenetic) – G2035
- Prostate Biopsy Specimen Analysis – G2007
- Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Disease – G2123
- Serum Testing for Evidence of Mild Traumatic Brain Injury – G2151
- Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease (Commercial, MA, D-SNP) – G2110
- Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease (FEP) – G2110
- Serum Tumor Markers for Malignancies (MA, D-SNP) – G2124
- Serum Tumor Markers for Malignancies (FEP) – G2124
- Testing for Alpha-1 Antitrypsin Deficiency – M2068
- Testing for Diagnosis of Active or Latent Tuberculosis (Commercial, MA, D-SNP) – G2063
- Testing for Diagnosis of Active or Latent Tuberculosis (FEP) – G2063
- Testing for Vector-borne Infections – G2158
- Thyroid Disease Testing (Commercial, MA, D-SNP) – G2045
- Thyroid Disease Testing (FEP) – G2045
- Urine Culture Testing for Bacteria – G2156
- Venous and Arterial Thrombosis Risk Testing – M2041
- Biomarker Testing for Autoimmune Rheumatoid Arthritis (FEP only) - G2022
- Diagnosis of Vaginitis (FEP only) - M2057
- Helicobacter Pylori Testing (FEP only) - G2044
- Onychomycosis Testing (FEP only) - M2172
- Prescription Medication and Illicit Drug Testing in the Outpatient Setting (Commercial only) - T2015
- Serum Tumor Markers for Malignancies – G2124
- Serum Tumor Markers for Malignancies (FEP only) - G2124
- Urinary Tumor Markers for Bladder Cancer - G2125
- B-Hemolytic Streptococcus Testing - G2159
- Biochemical Markers of Alzheimer Disease and Dementia - G2048
- Biomarkers for Myocardial Infarction and Chronic Heart Failure - G2150
- Bone Turnover Markers Testing - G2051
- Celiac Disease Testing - G2043
- Cervical Cancer Screening - G2002
- Diagnostic Testing of Common Sexually Transmitted Infections - G2157
- Diagnostic Testing of Influenza - G2119
- Epithelial Cell Cytology in Breast Cancer Risk Assessment - G2059
- Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing - G2060
- Fecal Calprotectin Testing - G2061
- Hepatitis Testing - G2036
- Immune Cell Function Assay - G2098
- Immunopharmacologic Monitoring of Therapeutic Serum Antibodies - G2105
- In Vitro Chemoresistance and Chemosensitivity Assays - G2100
- Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease - G2121
- Measurement of Thromboxane Metabolites for ASA Resistance - G2107
- Metabolite Markers for Thiopurines Testing - G2115
- Nerve Fiber Density Testing - M2112
- Prostate Biopsy Specimen Analysis - G2007
- Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases - G2123
- Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease - G2110
- Testing for Diagnosis of Active or Latent Tuberculosis - G2063
- Allergen Testing – G2031
- B-Hemolytic Streptococcus Testing - G2159
- Biochemical Markers of Alzheimer Disease and Dementia - G2048
- Biomarker Testing for Autoimmune Rheumatic Disease - G2022
- Biomarkers for Myocardial Infarction and Chronic Heart Failure - G2150
- Bone Turnover Markers Testing - G2051
- Cardiovascular Disease Risk Assesment - G2050
- Celiac Disease Testing - G2043
- Cervical Cancer Screening - G2002
- Coronavirus Testing in the Outpatient Setting - G2174
- Diabetes Mellitus Testing - G2006
- Diagnosis of Idiopathic Environmental Intolerance - G2056
- Diagnosis of Vaginitis including Multi-target PCR Testing - M2057
- Diagnostic Testing of Common Sexually Transmitted Infections - G2157
- Diagnostic Testing of Influenza - G2119
- Diagnostic Testing of Iron Homeostasis Metabolism - G2011
- Epithelial Cell Cytology in Breast Cancer Risk Assessment - G2059
- Evaluation of Dry Eyes Testing - G2138
- Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing - G2060
- Fecal Calprotectin Testing - G2061
- Flow Cytometry - F2019
- Folate Testing - G2154
- Gamma-Glutamyl Transferase - G2173
- General Inflammation Testing - G2155
- Helicobacter Pylori Testing - G2044
- Hepatitis C Testing - G2036
- HIV Genotyping and Phenotyping - M2093
- Human Immunodeficiency Virus (HIV) - M2116
- Identification of Microorganisms Using Nucleic Acid Probes - M2097
- Immune Cell Function Assay - G2098
- Immunohistochemistry - P2018
- Immunopharmacologic Monitoring of Therapeutic Serum Antibodies - G2105
- In Vitro Chemoresistance and Chemosensitivity Assays - G2100
- Intracellular Micronutrient Analysis - G2099
- Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease - G2121
- Lyme Disease Testing - G2143
- Measurement of Thromboxane Metabolites for ASA Resistance - G2107
- Metabolite Markers for Thiopurines Testing - G2115
- Nerve Fiber Density Testing - M2112
- Onychomycosis Testing - M2172
- Oral Cancer Screening and Testing - G2113
- Pancreatic Enzyme Testing for Acute Pancreatitis - G2153
- Parathyroid Hormone Phosphorus Calcium and Magnesium Testing - G2164
- Pathogen Panel Testing - G2149
- Pediatric Preventive Screening - G2042
- Prenatal Screening-Nongenetic - G2035
- Prescription Meds and Illicit Drug Testing in the Outpatient Setting - T2015
- Prostate Biopsies - G2007
- Salivary Hormone Testing - G2120
- Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases - G2123
- Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease
- Serum Tumor Markers for Malignancies - G2124
- Testing For Alpha-1 Antitrypsin Deficiency - M2068
- Testing for Diagnosis of Active or Latent Tuberculosis - G2063
- Testing for Vector-borne Infections - G2158
- Testosterone Testing - G2013
- Thyroid Disease Testing - G2045
- Urinary Tumor Markers for Bladder Cancer - G2125
- Urine Culture Testing for Bacteria - G2156
- Venous and Arterial Thrombosis Risk Testing - M2041
- Vitamin B12 Methylmalonic Acid Testing - G2014
- Vitamin D Testing - G2005
- Allergen Testing
- ANA/ENA Testing
- B-Hemolytic Streptococcus Testing
- Biochemical Markers of Alzheimer Disease and Dementia
- Bone Turnover Markers Testing
- Cardiac Biomarkers for Myocardial Infarction
- Cardiovascular Disease Risk Assessment
- Celiac Disease Testing
- Cervical Cancer Screening
- Coronavirus Testing in the Outpatient Setting
- Diagnosis of Idiopathic Environmental Intolerance
- Diagnosis of Vaginitis including Multi-target PCR Testing
- Diagnostic Testing of Common Sexually Transmitted Infections
- Diagnostic Testing of Influenza
- Diagnostic Testing of Iron Homeostasis Metabolism
- Epithelial Cell Cytology in Breast Cancer Risk Assessment
- Erectile Dysfunction
- Evaluation of Dry Eyes Testing
- Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing
- Fecal Calprotectin Testing in Adults
- Flow Cytometry
- Folate Testing
- Gamma-Glutamyl Transferase
- General Inflammation Testing
- Genetic Testing for Adolescent Idiopathic Scoliosis
- Helicobacter Pylori Testing
- Hemoglobin A1c
- Hepatitis C
- HIV Genotyping and Phenotyping
- Identification of Microorganisms Using Nucleic Acid Probes
- Immune Cell Function Assay
- Immunohistochemistry
- Immunopharmacologic Monitoring of Therapeutic Serum Antibodies
- In Vitro Chemoresistance and Chemosensitivity Assays
- Intracellular Micronutrient Analysis
- Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease
- Lyme Disease
- Measurement of Thromboxane Metabolites for ASA Resistance
- Metabolite Markers of Thiopurines Testing
- Nerve Fiber Density Testing
- Onychomycosis Testing
- Oral Screening Lesion Identification Systems and Genetic Screening
- Pancreatic Enzyme Testing for Acute Pancreatitis
- Parathyroid Hormone Phosphorus Calcium and Magnesium Testing
- Pathogen Panel Testing
- Pediatric Preventive Screening
- Plasma HIV-1 and HIV-2 RNA Quantification for HIV Infection
- Prenatal Screening-Nongenetic
- Prescription Medication and Illicit Drug Testing in Outpatient Setting
- Prostate Biopsies
- Salivary Hormone Testing
- Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases
- Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease
- Serum Tumor Markers for Malignancies
- ST2 Assay for Chronic Heart Failure
- Testing For Alpha-1 Antitrypsin Deficiency
- Testing for Diagnosis of Active or Latent Tuberculosis
- Testing for Mosquito or Tick Related Infections
- Testosterone Testing
- Thyroid Disease Testing
- Urinary Tumor Markers for Bladder Cancer
- Urine Culture Testing for Bacteria
- Venous and Arterial Thrombosis Risk Testing
- Vetra DA Blood Test for Rheumatoid Arthritis
- Vitamin B12 Methylmalonic Acid Testing
- Vitamin D Testing
- Zika Virus Risk Assessment
Enrollment
These documents contain information about your benefits, network and coverage.
- BlueCare Tennessee Behavioral Health Professional Services Information
- CAQH ProView®
- CAQH ProView - Frequently Asked Questions
- CAQH Proview News
- CAQH ProView Practice Manager Quick Reference Guide
- CAQH ProView Practice Manager User Guide
- CAQH ProView Provider Quick Reference Guide
- CAQH ProView Provider User Guide
- Medical Management Corrective Action Program
- Out Of Network Provider Form
- Provider Enrollment Updates and Changes Track a Request Guide
- Provider Change Form
Technical Support
These documents contain information about your benefits, network and coverage.
- 270 Companion Guide
- 276 Companion Guide
- 835 Companion Guide
- Dental Edits
- eBusiness Marketing Team Regional Map
- eBusiness User Guide
- EDI Corrected Claims Guidelines
- Electronic Claims Frequently Asked Questions (FAQs)
- Electronic Provider Profile Form
- Electronic Secondary Claim Guidelines
- Electronic Vendor Profile Form
- Institutional Edits
- Medicaid Reclamation New Carrier Form
- Medicaid Subrogation / Managed Care Organization / Medicaid Agencies Change Form
- NPI Line Level Adjudication Changes
- Professional Edits
- PWK Fax Cover Sheet
- Secure File Gateway Instructions (HTTPS)
- Secure File Gateway (SFG) Request For Access Form
- Supplemental BlueCare/TennCareSelect Edits
- Supplemental EDI Information
News and Updates
Details about new programs and changes to our procedures and guidelines.
BlueAlert Newsletters
- December 2024 BlueAlert
- November 2024 BlueAlert
- October 2024 BlueAlert
- September 2024 BlueAlert
- August 2024 BlueAlert
- July 2024 BlueAlert
- June 2024 BlueAlert
- May 2024 BlueAlert
- April 2024 BlueAlert
- March 2024 BlueAlert
- February 2024 BlueAlert
- January 2024 BlueAlert
- December 2023 BlueAlert
- November 2023 BlueAlert
- October 2023 BlueAlert
- September 2023 BlueAlert
- August 2023 BlueAlert
- July 2023 BlueAlert
- June 2023 BlueAlert
- May 2023 BlueAlert
- April 2023 BlueAlert
- March 2023 BlueAlert
- February 2023 BlueAlert
- January 2023 BlueAlert
Code Edits/Code Updates
- Code Editing for Facility High Level Emergency Room Services (July 1, 2024)
- Office and Outpatient Evaluation and Management Visit Complexity Add-on Payment Code G2211 (Effective Jan. 1, 2024)
- Ophthalmology Policies (Effective June 15, 2022)
Quality Care Quarterly Newsletter
The latest edition and archives of our monthly provider newsletter.
2025 BlueAlert Newsletter
The latest edition and archives of our quarterly quality newsletter.
- Spring
2025 Quality Care Newsletter
These documents contain information about upcoming code edits.
Here are the upcoming changes to prior authorization requirements.
- New PA Process for all LOB Effective December 2025
- Air Ambulance PA Process Effective December 2025
- Genetic Testing Code List Updates Effective 11.01.25
- Genetic Testing Code List Update Effective 09.30.2025
- New Commercial PA Submission Process Effective
- Gender Reassignment Code List Update Effective 08.03.2025
- MSK PA Changes Effective 05.01.2025
- BH Afterhours Notifications Effective 04.01.2025
- Genetic Testing Code List Updates Effective 01.01.2025